Oxford Science Enterprises’ Post

📽 Highlights from our #HealthTech Showcase! Earlier this summer, we had the privilege of hosting over 50+ investors to hear from our incredible #healthtech portfolio on how they're transforming healthcare on a global scale - redefining patient care, enhancing outcomes and setting new standards for the future of health. We're excited to continue this journey with the support of an amazing community of investors, partners and founders including: Amber Therapeutics, Aidan Crawley, Tim Denison, Ph.D. > Neuromodulation therapy to treat mixed urinary incontinence Caristo Diagnostics, Frank Cheng > AI technology for coronary inflammation detection Genomics plc, Peter Donnelly > Disease identification and prevention platform, powered by genomics Neu Health, Caroline Cake > Digital platform for Parkinson's & dementia care Refeyn, Gerry Mackay > Mass photometry technology Ultromics, Ross Upton, PhD > AI technology for heart disease detection Hosted by our very own Liliane Chamas, PhD. Video by Grace Gibbons and her incredible team at Bounce Video.

#PortfolioNews - Congratulations to Michael Lutz and the iotaSciences team for securing new funding to grow their automated single-cell biology handling technology. This investment will further help increase the speed and efficiency of cell biology research, driving forward new discoveries in biomedicine! The funding was supported by existing investors, including OSE, and welcomed new investment from the Oxford Innovation EIS Growth Fund managed by Oxford Innovation Finance. OSE´s Oliver Mahony said: “iotaSciences has delivered strong commercial performance over the last 12 months, doubling its installed base in Europe and the U.S and achieving its first placements in China through a recently announced distribution partnership. We are delighted to continue to support iotaSciences on its mission to become the leader in single-cell solutions for iPSC handling and other emerging high growth applications.” Read more about the announcement below ⤵ https://lnkd.in/e4AhmkiC

#portfolionews Congratulations to Walter Goodwin and the Fractile team for the completion of a new investment round, raising $15m to develop their revolutionary AI chip technology! The investment was co-led by OSE, Kindred Capital VC, and the NATO Innovation Fund (NIF).   OSE’s Sam Harman said: “Fractile has developed a radically innovative approach to solve one of the AI sector’s biggest challenges. We’re delighted to be supporting them and look forward to seeing the company accelerate its development while contributing to the UK’s growing reputation as an amazing place to build an AI company.”   Check out Walter’s interview with Fortune on the announcement here: https://lnkd.in/esdzV-rr   #AI #Innovation #TechFunding #FutureOfAI

✍ We're proud to support the launch of Oxford-Cambridge Supercluster Board's policy recommendations, sent to the UK government this week, on how we can supercharge economic growth via the UK's innovation sector. Our CEO Edward Bussey signed the letter sent to government, alongside 45+ leaders from the country's leading innovation businesses, advocating for the adoption of six critical policies to support the UK's position as a global leader in science and technology. Financial Times article on the initiative: https://lnkd.in/dq5VujkW Full details on the recommendations below ⤵

📣 Calling the next generation of healthcare innovators and VCs to participate in Oxford Venture Capital Network's first #HealthTech VC Programme! We're proud to collaborate with OXVC, alongside EQT Group, in the 3 month program kicking off in November 2024. OSE's Heather Roxborough and Tatiana Lobanov-Rostovsky will be on hand to provide mentorship and support to the participants throughout. Full details below: About the Programme: OXVC's Health Tech VC Programme is a 3-month training program designed to foster the next generation of healthcare innovators and venture capitalists. This program focuses on AI in diagnostics and therapeutics, among other emerging areas in health tech, providing you with the tools to transform research into real-world applications. Who Should Apply? We are looking for multidisciplinary teams that blend technological innovation with practical application and commercialization. If you are passionate about health tech and want to be part of a community that will shape the future of healthcare, please apply to join. A healthcare, STEM or business background is required, we are looking at DPhils, (E)MBAs and post-grads, but if you have a unique case to make for your application, we're open to hearing it.   How to Apply: The first round of applications is open now and closes on August 31st ⤵ 👉  https://lnkd.in/gyyC3G-4 👈

Congratulations to Sumi Biswas and the team at SpyBiotech on the completion of enrollment in their Phase I clinical trial for a vaccine targeting human cytomegalovirus (HCMV). HCMV is a common virus that can cause serious problems in newborns and individuals with weakened immune systems. There is no approved vaccine for this virus yet, and this achievement brings us one step closer to addressing this important health challenge.

#PortfolioNews - Congratulations to Caroline Cake and the team at Neu Health on the outcomes of their first NHS evaluation! This is a significant step towards enhancing Parkinson’s care and demonstrates the real-life impact of Neu Health’s pioneering technology. Read more about the announcement below ⤵

#PortfolioNews - Congratulations to Pete Armstrong and the team at Mixergy Ltd on their partnership with Daikin UK, a first for the industry! The combination of Daikin’s Altherma heat pump with Mixergy’s smart hot-water cylinder offers unparalleled benefits to social housing providers and new build developers, allowing them to deliver on their promise to provide better homes for homeowners and tenants while significantly reducing carbon emissions. Read more about the announcement ⤵ 

#PortfolioNews – Exciting news from the Oxford Semantic Technologies (OST) team who announced today that the company has been acquired by Samsung Electronics. Samsung will use OST’s RDFox® technology across a wide range of products, including mobile devices, televisions and home appliances. We’re extremely proud to have supported OST since it was spun out of the Oxford University Computer Science Department in 2017. It is a great example of how developments in deep tech can be deployed in consumer technology, with RDFox® set to be integrated into appliances in homes around the world. Full announcement here ⤵ https://lnkd.in/e9if_Pfn